These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9368828)

  • 1. Estimation of the cost savings resulting from the use of ursodiol for the prevention of gallstones in obese patients undergoing rapid weight reduction.
    Shoheiber O; Biskupiak JE; Nash DB
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1038-45. PubMed ID: 9368828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss.
    Sugerman HJ; Brewer WH; Shiffman ML; Brolin RE; Fobi MA; Linner JH; MacDonald KG; MacGregor AM; Martin LF; Oram-Smith JC
    Am J Surg; 1995 Jan; 169(1):91-6; discussion 96-7. PubMed ID: 7818005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass.
    Scott DJ; Villegas L; Sims TL; Hamilton EC; Provost DA; Jones DB
    Surg Endosc; 2003 Nov; 17(11):1796-802. PubMed ID: 12958683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
    Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
    Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
    BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary?
    Caruana JA; McCabe MN; Smith AD; Camara DS; Mercer MA; Gillespie JA
    Surg Obes Relat Dis; 2005; 1(6):564-7; discussion 567-8. PubMed ID: 16925292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
    Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
    J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.
    Worobetz LJ; Inglis FG; Shaffer EA
    Am J Gastroenterol; 1993 Oct; 88(10):1705-10. PubMed ID: 8213711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?
    Swartz DE; Felix EL
    Surg Obes Relat Dis; 2005; 1(6):555-60. PubMed ID: 16925290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ursodiol or ibuprofen on contraction of gallbladder and bile among obese patients during weight loss.
    Marks JW; Bonorris GG; Schoenfield LJ
    Dig Dis Sci; 1996 Feb; 41(2):242-9. PubMed ID: 8601365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial.
    Miller K; Hell E; Lang B; Lengauer E
    Ann Surg; 2003 Nov; 238(5):697-702. PubMed ID: 14578732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis.
    Uy MC; Talingdan-Te MC; Espinosa WZ; Daez ML; Ong JP
    Obes Surg; 2008 Dec; 18(12):1532-8. PubMed ID: 18574646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man.
    Marks JW; Stein T; Schoenfield LJ
    Dig Dis Sci; 1994 Sep; 39(9):1981-4. PubMed ID: 8082507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallbladder management in obesity surgery.
    Mason EE; Renquist KE
    Obes Surg; 2002 Apr; 12(2):222-9. PubMed ID: 11975217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of obesity and weight loss to gallstone disease.
    Everhart JE
    Ann Intern Med; 1993 Nov; 119(10):1029-35. PubMed ID: 8214980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management of gallstones: a cost-effectiveness analysis.
    Weinstein MC; Coley CM; Richter JM
    J Gen Intern Med; 1990; 5(4):277-84. PubMed ID: 2115575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computer model for evaluating the costs of cholecystectomy or ursodiol treatment in the management of cholelithiasis.
    Crain K
    Clin Ther; 1990; 12(3):250-62. PubMed ID: 2379230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ref: Gallstone formation in obese subjects undergoing a weight reduction diet.
    Morán S; Milke P; Rodríguez-Leal G; Uribe M
    Int J Obes Relat Metab Disord; 1998 Mar; 22(3):282-4. PubMed ID: 9539199
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of fiber administration in the prevention of gallstones in obese patients on a reducing diet. A clinical trial].
    Morán S; Uribe M; Prado ME; de la Mora G; Muñoz RM; Pérez MF; Milke P; Blancas JM; Dehesa M
    Rev Gastroenterol Mex; 1997; 62(4):266-72. PubMed ID: 9580234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein-E genotype and the risk of developing cholelithiasis following bariatric surgery: a clue to prevention of routine prophylactic cholecystectomy.
    Abu Abeid S; Szold A; Gavert N; Goldiner I; Grynberg E; Peretz H; Konikoff FM
    Obes Surg; 2002 Jun; 12(3):354-7. PubMed ID: 12087994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.